|
Real-time Estimate
Cboe BZX
04:47:33 06/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 25.26 USD | +6.70% |
|
+5.29% | -45.36% |
Company Valuation: Collegium Pharmaceutical, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 650 | 778.9 | 1,004 | 924 | 1,464 | 770.6 | - | - |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -47.35% | - | - |
| Enterprise Value (EV) | 650 | 778.9 | 1,004 | 924 | 1,464 | 770.6 | 770.6 | 770.6 |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -47.35% | 0% | 0% |
| P/E | 10x | -31.4x | 23.9x | 15.4x | 26.8x | 21.2x | 6.62x | 4.82x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | -0x | 0.3x | -3.83x | -0.6x | 0x | 0.1x |
| Capitalization / Revenue | 2.35x | 1.68x | 1.77x | 1.46x | 1.88x | 0.92x | 0.91x | 0.91x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.92x | 0.91x | 0.91x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.72x | 1.86x | 2.05x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 1.72x | 1.92x | 2.05x |
| EV / FCF | - | - | 0x | 0x | 0x | 2.74x | 2.15x | 1.95x |
| FCF Yield | - | - | 27.3% | 22% | 22.4% | 36.5% | 46.5% | 51.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.86 | -0.74 | 1.29 | 1.86 | 1.73 | 1.117 | 3.573 | 4.915 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 276.9 | 463.9 | 566.8 | 631.4 | 780.6 | 833.1 | 844.5 | 849.1 |
| EBITDA 1 | 118.3 | 266 | 367 | 401.2 | 460.5 | 447.9 | 413.7 | 375.1 |
| EBIT 1 | 17.63 | 33.32 | 167 | 169.9 | 179.6 | 448.9 | 402.1 | 376.5 |
| Net income 1 | 71.52 | -25 | 48.16 | 69.19 | 62.87 | 28.73 | 83.33 | 152.7 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.68 | 23.20 | 30.78 | 28.65 | 46.30 | 23.67 | 23.67 | 23.67 |
| Nbr of stocks (in thousands) | 34,797 | 33,572 | 32,611 | 32,250 | 31,611 | 32,556 | - | - |
| Announcement Date | 24/2/22 | 23/2/23 | 22/2/24 | 27/2/25 | 26/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.2x | - | - | - | 771M | |
| 41.5x | 14.02x | 31.15x | 0.48% | 1,263B | |
| 40.44x | 6.79x | 19.1x | 1.93% | 665B | |
| 37.93x | 8.6x | 17.74x | 2.35% | 521B | |
| 21.34x | 5.18x | 12.9x | 2.53% | 387B | |
| 99.59x | 6.08x | 25.91x | 2.26% | 371B | |
| 23.46x | 6.01x | 14.51x | 2.66% | 310B | |
| 24.81x | 4.95x | 13.96x | 1.76% | 293B | |
| 29.96x | 7.59x | 13.11x | 2.11% | 259B | |
| -41.77x | 7.6x | 47.71x | 1.89% | 216B | |
| Average | 29.85x | 7.42x | 21.79x | 2% | 428.62B | |
| Weighted average by Cap. | 36.76x | 8.84x | 22.92x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLL Stock
- Valuation Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
